Author:
Schyf Cornelis J. Van der,Geldenhuys Werner J.,Youdim Moussa B. H.
Reference90 articles.
1. Akk, G., & Steinbach, J. H. (2005). Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site. Journal of. Neuroscience, 25, 1992–2001.
2. Arundine, M., & Tymianski, M. (2004). Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cellular and Molecular Life Sciences, 61, 657–668.
3. Avramovich, Y., Amit, T., & Youdim, M. B. H. (2002). Non-steroidal anti-inflammatory drugs stimulate secretion of non-amyloidogenic precursor protein. Journal of Biological Chemistry, 277, 31466–31473.
4. Avramovich-Tirosh, Y., Reznichenko, L., Amit, T., Zheng, H., Fridkin, M., Weinreb, O., et al. (2006). Neurorescue Activity, APP Regulation and Amyloid-β Peptide Reduction by Novel Multi-Functional Brain Permeable Iron- Chelator- Antioxidants, M-30 and Green Tea Polyphenol, EGCG. Current Alzheimers Disease Research (in press).
5. Ben Shachar, D., Kahana, N., Kampel, V., Warshawsky, A., & Youdim, M. B. H. (2004). Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats. Neuropharmacology, 46, 254–263.